FORMULIERUNGEN EINES SOMATOSTATIN-MODULATORS

European patent · EP4210700 · In force

Register entry

Publication number
EP4210700
Application number
EP21786673
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 7, 2021
Published
Jul 19, 2023
Granted
Aug 6, 2025
Protection ends at the latest
Sep 6, 2041
Next annual fee due
Sep 30, 2027
IPC classes
A61K 31/472 (2006.01)
A61K 9/14 (2006.01)
A61K 9/16 (2006.01)
A61K 9/20 (2006.01)
A61P 5/08 (2006.01)
A61K 9/48 (2006.01)
A61K 31/4709 (2006.01)
Priority
US 202063076024 P 09.09.2020
PCT application
PCT/US2021/049282 07.09.2021
PCT publication
WO2022/055880 17.03.2022
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Jun 17, 2026

    Change

    Published in Swissreg on 17.06.2026

  3. Oct 30, 2025

    Agent entered

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 30.10.2025

  4. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  5. Aug 6, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 06.08.2025

Parties

Inventor

BURKE, Gerald

San Diego, California 92121, US

YATES, Ian

Bend, Oregon 97703, US

BULOVSKY, Hannah

Bend, Oregon 97703, US

KYBURZ, Kyle

Bend, Oregon 97703, US

TYLER, Clayton

Bend, Oregon 97703, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.